Is it cost-effective to use a test to decide which individuals with an intermediate cardiovascular disease risk would benefit from statin treatment?

LT (Laura) Burgers, Sjoerd Nauta, Jaap Deckers, Hans Severens, Ken Redekop

Research output: Contribution to journalArticleAcademicpeer-review

7 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)980-987
Number of pages8
JournalInternational Journal of Cardiology
Volume176
Issue number3
DOIs
Publication statusPublished - 2014

Research programs

  • EMC NIHES-05-63-02 Quality
  • EMC COEUR-09

Cite this